allergy banner

Videos


Articles


Successful usage of a chatbot to standardize and automate history taking in Hymenoptera venom allergy.

Schneider, S., Gasteiger, C., Wecker, et al. Allergy. First published: 22 March 2023

Atopic dermatitis: correlation of distinct risk factors with age of onset in adulthood compared to childhood

Maintz, L., Schmitz, M.-T., Herrmann, N., et al. Allergy. First published: 22 March 2023

Trait profiles in difficult-to-treat asthma: clinical impact and response to systematic assessment

Lin, T., Jonathan, P., Denton, E., et al. Allergy. First published: 20 March 2023

Legends of Allergy: Gianni Marone

Triggiani, M., Casolaro, V. and Stellato, C. Allergy. First published: 19 March 2023

Global Initiative for Asthma (GINA): 30 years of promoting evidence-based asthma care

Yorgancıoğlu, A., Reddel, H.K. Allergy. First published: 18 March 2023

Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both

Pfeffer, P.E., Ali, N., Murray, R., et al. Allergy. First published: 17 March 2023

Severe and refractory anaphylaxis in paediatric intensive care unit

Pouessel, G., Trochu, C., Chagnon, F., et al. Allergy. First published: 17 March 2023

Prescribing patterns of budesonide/formoterol maintenance and reliever therapy in patients with asthma in Sweden

Janson, C., Melén, E., Licht, S.d.F., et al. Allergy. First published: 15 March 2023

pH sensing shapes immune cell function: The role of GPR65 and its implications for allergic disease

de Souza Ferreira, S., Bek, M.K. and Tibbitt, C.A. Allergy. First published: 14 March 2023

Immune Response Evolution in Peanut Epicutaneous Immunotherapy for Peanut-Allergic Children

Bastin, M., Carr, W.W., Davis, C.M., et al. Allergy. First published: 14 March 2023

PM2.5 chemical constituents and allergic rhinitis: Findings from a prospective cohort study in China

Jia, P., Feng, C., Ye, T., Shao, Y. and Yang, S. Allergy. First published: 11 March 2023

Quantitative analysis of urinary cytokines in food-allergic and healthy individuals

Lee, A.S., Parsons, E.S., Chang, I., et al. Allergy. First published: 11 March 2023

An alternative path to oral tolerance

Li, C.H., Kabak, E. and Eiwegger, T. Allergy. First published: 08 March 2023

Acute and Chronic Impacts of Heat Stress on Planetary Health

Sampath, V., Shalakhti, O., Veidis, E., et al. Allergy. First published: 08 March 2023

Dupilumab treatment increases transitional B cells in severe asthma

Lommatzsch, M., Dost, M., Jaishankar, N., et al. Allergy. First published: 08 March 2023

The next generation virus-like particle platform for the treatment of peanut allergy

Sobczak, J.M., Krenger, P.S., Storni, F., et al. Allergy. First published: 08 March 2023

IL-4 drastically decreases deuterosomal and multiciliated cells via alteration in progenitor cell differentiation

Cho, H-J, Chung, YW, Moon, S, et al. Allergy. First published: 08 March 2023

Microglia–neuron interactions promote chronic itch via the NLRP3-IL-1β-GRPR axis

Liu, X, Wang, Y, Zeng, Y, et al. Allergy. First published: 06 March 2023

Determinants of bone density in children with immunoglobulin E-mediated food allergy

Nichols-Vinueza, D.X., Mateja, A., Hatzimemos, A., et al. Allergy. First published: 05 March 2023

Detection of gut and mucosal peptides through TOMAHAQ in healthy individuals

Parsons, E.S., Liu, F., Kaushik, A., et al. Allergy. First published: 05 March 2023

Factors associated with suboptimal response to monoclonal antibodies in severe asthma

Pérez de Llano, L., Marina Malanda, N., Urrutia, I., et al. Allergy. First published: 03 March 2023

In vivo and ex vivo inflammatory responses of the esophageal mucosa to food challenge in adults with eosinophilic esophagitis

Haasnoot, M.L., Kleuskens, M.T.A., Lopez-Rincon, A., et al. Allergy. First published: 03 March 2023

BTEX exposure and its body burden pose differential risks for asthma and its phenotypic clusters

Hsu, Y.-T., Wu, C.-C., Wang, C.-C., et al. Allergy. First published: 28 February 2023

Adult asthma with symptomatic eosinophilic inflammation is accompanied by alteration in gut microbiome

Gu, B.-H., Choi, J.-P., Park, T., et al. Allergy. First published: 27 February 2023

A molecular sensitization map of European children reveals exposome- and climate-dependent sensitization profiles

Kiewiet, M.B.G., Lupinek, C., Vrtala, S., et al. Allergy. First published: 23 February 2023

Induction of immunosuppressive CD39 but not the trafficking C-C chemokine receptor 4 on Treg during LAR in mite allergic asthma

Doyen, V., Poirot, A., Maumy-Bertrand, M., et al. Allergy. First published: 22 February 2023

Early increase in serum specific IgG2 upon allergen immunotherapy with a 300 IR sublingual house dust mite tablet

Berjont, N., Bordas-Le Floch, V., O’Hehir, R.E., et al. Allergy. First published: 21 February 2023

The immune-supportive diet in allergy management. A narrative review and proposal

Vlieg-Boerstra, B., Groetch, M., Vassilopoulou, E., et al. Allergy. First published: 21 February 2023

Citations: 86

The role of peripheral blood eosinophil counts in COVID-19 patients

Xie, G, Ding, F, Han, L, Yin, D, Lu, H, Zhang, M. Allergy. 2021; 76: 471– 482

Citations: 66

The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria

Zuberbier, T, Abdul Latiff, AH, Abuzakouk, M, Aquilina, S, Asero, R, Baker, D, et al. Allergy. 2022; 77: 734– 766

Citations: 66

EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines

Sokolowska, M., Eiwegger, T., Ollert, M., Torres, M.J., Barber, D., Del Giacco, S., et al. Allergy. 2021; 76: 1629-1639

Citations: 66

COVID-19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper

Pfaar, O, Klimek, L, Jutel, M, Akdis, C, A, Bousquet, J, Breiteneder, H, et al. Allergy. 2021; 76: 648– 676

Citations: 64

ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines – An EAACI-ARIA Position Paper

Klimek, L., Jutel, M., Akdis, C.A., Bousquet, J., Akdis, M., Torres, M.J., et al. Allergy. 2021; 76: 1624-1628

Citations: 58

Allergic reactions to the first COVID-19 vaccine: A potential role of polyethylene glycol?

Cabanillas, B., Akdis, C.A. and Novak, N. Allergy. 2021; 76: 1617-1618

Citations: 53

Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation

Klimek, L., Novak, N., Cabanillas, B., Jutel, M., Bousquet, J. and Akdis, C.A. Allergy. 2021; 76: 3307-3313

Citations: 41

EAACI guidelines: Anaphylaxis (2021 update)

Muraro, A, Worm, M, Alviani, C, Cardona, V, DunnGalvin, A, Garvey, L, H, et al et al. Allergy. 2022; 2022; 77: 357– 377

Citations: 41

Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives

Sampath, V., Rabinowitz, G., Shah, M., Jain, S., Diamant, Z., Jesenak, M., et al. Allergy. 2021; 76: 1640-1660

Citations: 38

Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort

Papadopoulos, N.G., Mathioudakis, A.G., Custovic, A., Deschildre, A., Phipatanakul, W., Wong, G., et al. Allergy. 2021; 76: 1765-1775

Citations: 35

Anaphylaxis to the first dose of mRNA SARS-CoV-2 vaccines: Don't give up on the second dose!

Krantz, M.S., Bruusgaard-Mouritsen, M.A., Koo, G., Phillips, E.J., Stone, C.A., Jr and Garvey, L.H. Allergy. 2021; 76: 2916-2920

Citations: 35

Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines

Agache, I., Song, Y., Alonso-Coello, P., Vogel, Y., Rocha, C., Solà, I., et al. Allergy. 2021; 76: 2337-2353

Citations: 34

In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion

Augusto, G, Mohsen, MO, Zinkhan, S, Liu, X, Vogel, M, Bachmann, MF. Allergy. 2022; 77: 111– 117

Citations: 33

Basophil activation test: Mechanisms and considerations for use in clinical trials and clinical practice

Santos, A.F., Alpan, O. and Hoffmann, H.-J. Allergy. 2021; 76: 2420-2432

Citations: 32

Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19

Adamo, S., Chevrier, S., Cervia, C., Zurbuchen, Y., Raeber, M.E., Yang, L., et al. Allergy. 2021; 76: 2866-2881

Citations: 32

Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity

Torres, MJ, Trautmann, A, Böhm, I, Scherer, K, Barbaud, A, Bavbek, S, et al. Allergy. 2021; 76: 1325– 1339

Citations: 31

The role of allergen-specific IgE, IgG and IgA in allergic disease

Shamji, MH, Valenta, R, Jardetzky, T, Verhasselt, V, Durham, S, R, Würtzen, P, A, et al. Allergy. 2021; 76: 3627– 3641

Citations: 30

Elastase and exacerbation of neutrophil innate immunity are involved in multi-visceral manifestations of COVID-19

Guéant, J.-L., Guéant-Rodriguez, R.-M., Fromonot, J., Oussalah, A., Louis, H., Chery, C., et al. Allergy. 2021; 76: 1846-1858

The second COVID-19 mRNA vaccine dose enhances the capacity of Spike-specific memory B cells to bind Omicron BA.2

Hartley, G.E., Edwards, E.S.J., Varese, N., et al. Allergy. First published: 21 December 2022

Recent developments in the immunopathology of COVID-19

Zhang, H.-p., Sun, Y.-l., Wang, Y.-f., et al. Allergy. First published: 24 November 2022

Immediate hypersensitivity reactions to anti-SARS-CoV-2 neutralizing monoclonal antibodies: a real-life experience

Franceschini, L. and Farsi, A. Allergy. First published: 16 November 2022

The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients

Ungar, B., Hartzell, S., Lozano-Ojalvo, D., et al. Allergy. First published: 01 October 2022

Disproportionate rate of female referrals for suspected COVID-19 vaccine allergies

Chiang, V., Kan, A.K.C., Yim, J.S.H., et al. Allergy. First published: 20 September 2022

Drug hypersensitivity, in vitro tools, biomarkers, and burden with COVID-19 vaccines

Palomares, F., Paris, J.L., Labella, M., Doña, I., Mayorga, C. and Torres, M.J. Allergy. First published: 01 August 2022

Exposure to avian coronavirus vaccines is associated with increased levels of SARS-CoV-2-cross-reactive antibodies

Ardicli, O, Carli, KT, Satitsuksanoa, P, et al. et al. Allergy. First published: 23 July 2022

Urticaria and/or angioedema secondary to mRNA COVID-19 vaccines: Updates from a United States case registry

Anvari, S., Samarakoon, U., Fu, X., et al. Allergy. First published: 16 July 2022

The nasopharyngeal and salivary microbiomes in COVID-19 patients with and without asthma

Kim, J.G., Zhang, A., Rauseo, A.M., et al. Allergy. First published: 15 July 2022

Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity

Worm, M., Alexiou, A., Bauer, A., et al. Allergy. First published: 20 June 2022

Immune-inflammatory proteome of elite ice hockey players before and after SARS-CoV-2 infection

Maurer, D.J., Barletta, E., Heider, A., et al. Allergy. First published: 12 June 2022

T cell recovery and evidence of persistent immune activation 12 months after severe COVID-19

Taeschler, P., Adamo, S., Deng, Y., et al. Allergy. First published: 14 May 2022

Long-term effects of homologous and heterologous SARS-CoV-2 vaccination on humoral and cellular immune responses

Hollstein, M.M., Münsterkötter, L., Schön, M.P., et al. Allergy. First published: 14 May 2022

COVID-19 in the absence of eosinophils: The outcome of confirmed SARS-CoV-2 infection whilst on treatment with benralizumab

Francis, C.H.R., Hearn, A.P., Ratnakumar, S., et al. Allergy. First published: 01 May 2022

Intranasal administration of a VLP-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern

Rothen, D.A., Krenger, P.S., Nonic, A., et al. Allergy. First published: 11 April 2022

Autoantibodies in COVID-19 correlate with anti-viral humoral responses and distinct immune signatures

Taeschler, P., Cervia, C., Zurbuchen, Y., et al. Allergy. First published: 01 April 2022

Vaccine based on folded RBD-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants

Gattinger, P., Kratzer, B., Tulaeva, I., et al. Allergy. First published: 31 March 2022

Are health care policies for COVID-19 evidence-based?

Bonini, S. and Fiorito, S. Allergy. First published: 30 March 2022

Virus-related stimuli modulate SARS-CoV-2 entry factor expression in pediatric tonsillar epithelial cells in vitro

Hara, M., Morimoto, N., Watabe, T., et al. Allergy. First published: 29 March 2022

Do basophil activation tests help elucidate allergic reactions to the ingredients in COVID-19 vaccines?

Eberlein, B., Sonja, M., Fischer, J., Darsow, U., Biedermann, T. and Brockow, K. Allergy. First published: 10 March 2022

Humoral immune response of Sinopharm/BBIBP COVID-19 vaccination before and after the booster immunization

Cheng, Z.J., Huang, H., Zheng, P., et al. Allergy. First published: 07 March 2022

The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414

Risk factors for severe and critically ill COVID-19 patients: A review

Gao, Y-D, Ding, M, Dong, X, et al. Allergy. 2021; 76: 428– 455

Vaccines and allergic reactions: the past, the current COVID-19 pandemic, and future perspectives

Sampath, V., Rabinowitz, G., Shah, M., Jain, S., Diamant, Z., Jesenak, M. et al. Allergy. 2021; 76: 1640-1660

Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19

Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581

EAACI guidelines: Anaphylaxis (2021 update)

Muraro, A, Worm, M, Alviani, C, et al. Allergy. 2022; 77: 357– 377

Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China

Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741

Advances and recent developments in asthma in 2020

Cevhertas, L, Ogulur, I, Maurer, DJ, et al. Allergy. 2020; 75: 3124– 3146

The international WAO/EAACI guideline for the management of hereditary angioedema – the 2021 revision and update

Maurer, M., Magerl, M., Betschel, S., et al. Allergy. First published: 10 January 2022

A compendium answering 150 questions on COVID-19 and SARS-CoV-2

Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541

Management of anaphylaxis due to COVID-19 vaccines in the elderly

Bousquet, J., Agache, I., Blain, H., et al. Allergy. 2021; 76: 2952-2964

Predictors of treatment response in chronic spontaneous urticaria

Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981

Interleukin-31: The “itchy” cytokine in inflammation and therapy

Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997

Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review

Mostmans, Y., De Smedt, K., Richert, B., et al. Allergy. 2021; 76: 2998-3016

Eczema herpeticum in atopic dermatitis

Traidl, S., Roesner, L., Zeitvogel, J. and Werfel, T. Allergy. 2021; 76: 3017-3027

Heterogeneity of pollen food allergy syndrome in seven Southern European countries: The @IT.2020 multicenter study

Lipp, T, Acar Şahin, A, Aggelidis, X, et al. Allergy. 2021; 76: 3041– 3052

Direct assessment of individual skin barrier components by electrical impedance spectroscopy

Mannweiler, R., Bergmann, S., Vidal-y-Sy, S., Brandner, J.M. and Günzel, D. Allergy. 2021; 76: 3094-3106

Prenatal paraben exposure and atopic dermatitis-related outcomes among children

Thürmann, L, Herberth, G, Seiwert, B, et al. Allergy. 2021; 76: 3122– 3132

Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis

Kopfnagel, V, Dreyer, S, Zeitvogel, J, et al. Allergy. 2021; 76: 3145– 3154

Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy

Tesfaye, A., Rodríguez-Nogales, A., Benedé, S., et al. Allergy. 2021; 76: 3183-3193

Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine

Darrigade, A.-S., Théophile, H., Sanchez-Pena, P., et al. Allergy. 2021; 76: 3194-3196

Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma

Lommatzsch, M., Klein, M., Stoll, P. and Virchow, J.C. Allergy. 2021; 76: 3199-3202

Identification of Ulocladium chartarum as an important indoor allergen source

Pfeiffer, S., Sandler, P., Raith, M., et al. Allergy. 2021; 76: 3202-3206

Effects of allergen immunotherapy in the MASK-air study: a proof-of-concept analysis

Pfaar, O., Sousa-Pinto, B., Devillier, P., et al. Allergy. 2021; 76: 3212-3214

Legends of allergy and immunology: Sergio Bonini

Maltese, G. and Rasi, G. Allergy. 2021; 76: 3227-3229

Medical algorithm: Peri-operative management of mastocytosis patients

Bocca-Tjeertes, I.F.A., van de Ven, A.A.J.M., Koppelman, G.H., et al. Allergy. 2021; 76: 3233-3235

Open Access Agreements with Wiley



Check here if your research institution has an agreement with Wiley to make your Original Articles and Review Articles free to read, download and share by everyone: Institutional Payments | Wiley

Free access

17th World Immune Regulation Meeting



As ever, immune regulation is the hottest issue in basic and clinical sciences. With an outstanding list of speakers in this field, WIRM will be one of the key scientific event of the year 2023, being big enough to learn from other disciplines and small enough to personally meet the experts. Check out the website for more information by clicking here.
WIRM

Junior Members Corner



Dear Junior Members,

The EAACI Winter School 2023 has been a great success! This year, on the occasion of the 20th anniversary of the meeting, it was held in Davos, Switzerland, the place where it was first held!

During 4 exciting days (26-29 January 2023), 70 Junior Members from all over the world had the opportunity to share their innovative results related to allergy and Immunology. For the first time, the meeting had an innovative format. On the first day, we enjoyed inspiring talks by Liam O'Mahony, Oscar Palomares, Mary Prunicki and Sirpa Pietikainen. You can see again these talks at the EAACI Knowledge Hub.

We also enjoyed the 6 keynote lectures by leading experts in their fields, the 20 oral presentations by Junior Members with a wide variety of topics and the 48 poster presentations, where we were able to discuss a lot about our studies and results, with inspiring interaction with faculties and with other Juniors. The experience was very enriching, and our research has certainly improved a lot.

In addition, we had the opportunity to visit the Swiss Institute for Allergy and Asthma Research (SIAF). There, we see the facilities and equipment on confocal microscopy, flow cytometry, classification, mass spectrometry... explained by SIAF members. Moreover, we can work in small groups during workshop sessions to discuss about what we already know and unmet needs in relation to Environment and Immunology. After the discussions, on the last day, each group presented its conclusions to all participants, and the outcome of these workshops was a total success!

We cannot forget to mention the networking activities and the important interaction between the participants during breakfast, lunch, and dinner, characteristic of this meeting.

The Winter School was a great success! We hope to see you again next year in Zakopane (Poland).

Best regards,
The Junior Member Assembly